Similar articles

• [Rituximab (antiCD20 monoclonal antibody) and molecular-biological negativity in the treatment of patients with follicular lymphoma--a way to a cure?--Editorial].

  Trnený M. Trnený M. Vnitr Lek. 2007 Oct;53(10):1029-30. Vnitr Lek. 2007. PMID: 18072423 Czech. No abstract available.
• Therapeutic opportunities for counteracting apoptosis resistance in childhood leukaemia.

  Fulda S. Fulda S. Br J Haematol. 2009 May;145(4):441-54. doi: 10.1111/j.1365-2141.2009.07603.x. Br J Haematol. 2009. PMID: 19298593 Review.
• Advances in treating lymphatic cancer. High-dose chemotherapy plus stem-cell support improves survival for some people with non-Hodgkin's lymphoma.

  Bona R. Bona R. Health News. 2004 May;10(5):4-5. Health News. 2004. PMID: 15132104 No abstract available.
• [Molecular target therapy for malignant lymphoma].

  Suzuki R. Suzuki R. Rinsho Ketsueki. 2008 Jan;49(1):18-29. Rinsho Ketsueki. 2008. PMID: 18277592 Review. Japanese. No abstract available.
• [Gastrointestinal lymphoma].

  Fischbach W, Daum S. Fischbach W, et al. Dtsch Med Wochenschr. 2003 Sep 12;128(37):1899-901. doi: 10.1055/s-2003-42154. Dtsch Med Wochenschr. 2003. PMID: 12970824 Review. German. No abstract available.